Assessment clinic for patients recovering from COVID-19
The Nottingham Recovery From COVID-19 Research Platform Assessment Clinic
This study is setting up a clinic to help people who are recovering from COVID-19 and are dealing with ongoing health problems, to see how the virus has affected them in the long run.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nottingham University Hospitals NHS Trust Academic / other |
| Locations | 1 site (Nottingham) |
| Trial ID | NCT04710836 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a research clinic in Nottingham and Nottinghamshire to investigate the long-term effects of COVID-19 on patients. It focuses on individuals who have experienced significant morbidity after COVID-19, particularly those who were not hospitalized. The clinic will facilitate research and learning about the ongoing health issues faced by this population, including respiratory complications, fatigue, and other systemic effects. Insights gained will support future clinical trials and service planning.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have had a clinical diagnosis of COVID-19 and are experiencing significant ongoing health issues.
Not a fit: Patients who are under 18 years old or those already included in the PHOSP-COVID study will not benefit from this clinic.
Why it matters
Potential benefit: If successful, this initiative could lead to improved understanding and management of long-term COVID-19 complications for patients.
How similar studies have performed: While this approach is novel in its specific focus on non-hospitalized COVID-19 patients, other studies have explored long-term effects of COVID-19 with varying degrees of success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years) referred into the post COVID-19 respiratory outpatient clinic from primary care, following a swab, imaging or strong clinical diagnosis of COVID-19 * Adults discharged from hospital with a clinical diagnosis of COVID-19 (who are not included in the PHOSP-COVID study) Exclusion Criteria: * Children (\<18 years) referred into the post COVID-19 respiratory outpatient clinic. This clinic is only open to adults and referrals for children will not be accepted * Adults discharged from hospital with a clinical diagnosis of COVID-19 and have been included in the PHOSP-COVID study * Patients unable to provide informed consent by themselves
Where this trial is running
Nottingham
- Nottingham City Hospital — Nottingham, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Charlotte Bolton — University of Nottingham & Nottingham University Hospitals NHS Trust
- Study coordinator: Charlotte Bolton
- Email: charlotte.bolton@nottingham.ac.uk
- Phone: 01159 691169
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.